TKDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 14.7 EUR 2.08% Market Closed

Market Cap: €46.6B

T	Takeda Pharmaceutical Co Ltd F:TKDA	JP
	NRJ Group SA F:NR8	FR
U	Unum Group XMUN:UUM	US
H	Hamborner REIT AG LSE:0MCG	DE
	PSP Projects Ltd NSE:PSPPROJECT	IN
H	Hamborner REIT AG XHAM:HABA	DE
	Hamborner REIT AG XETRA:HABA	DE
R	Ryder System Inc DUS:RYD	US
N	Nomura Holdings Inc F:NSE	JP

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

11%

Declining Operating Margin

13% > 11%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

7% > 3%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.